Edward Pan

The Kids Research Institute Australia — Australia

Medicine · Health Sciences

36h-index3.7kcitations157works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(71), Immunotherapy and Immune Responses(15), Brain Metastases and Treatment(13), CAR-T cell therapy research(12), Advanced MRI Techniques and Applications(11)

Publications151 total

Characteristics, treatment and lung function outcomes of pulmonary exacerbations in cystic fibrosis: insights from the BEAT-CF cohort
European Respiratory Journal·2025· 1 cited
TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC).
Journal of Clinical Oncology·2025· 11 cited
BEAT-CF (Bayesian Evidence Adaptive Treatment for people with Cystic Fibrosis): description of a prospective cohort for nested studies in cystic fibrosis
Respiratory Medicine·2025· 1 citedOpen Access
Robust Cluster Prediction Across Data Types Validates Association of Sex and Therapy Response in GBM
Cancers·2025· 1 citedOpen Access
TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer
Future Oncology·2024· 11 citedOpen Access
Trimodal skin health programme for childhood impetigo control in remote Western Australia (SToP): a cluster randomised, stepped-wedge trial
The Lancet Child & Adolescent Health·2024· 13 cited
Multi-methods process evaluation of the SToP (See, Treat, Prevent) trial: a cluster randomised, stepped wedge trial to support healthy skin
EClinicalMedicine·2024· 7 citedOpen Access
Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC): Subgroup analysis from TROPION-Lung02.
Journal of Clinical Oncology·2024· 6 cited
Multi-Methods Evaluation of the Stop (See, Treat, Prevent) Trial: A Cluster Randomised, Stepped Wedge Trial to Support Healthy Skin
SSRN Electronic Journal·2024Open Access
Stop (See, Treat, and Prevent) Activities for Skin Disease Control in Remote Western Australia: A Cluster Randomised, Stepped Wedge Trial
SSRN Electronic Journal·2024· 1 citedOpen Access
1505TiP TROPION-Lung07: A phase III trial of datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy in advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC) with PD-L1 expression
Annals of Oncology·2023· 5 citedOpen Access
Potential Molecular Targets in the Treatment of Patients with CNS Tumors
Cancers·2023· 1 citedOpen Access
TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) in advanced non-small cell lung cancer (aNSCLC).
Journal of Clinical Oncology·2023· 50 cited
Supplementary Figure Legends from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
2023Open Access
Supplementary fig 2 from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
2023Open Access
Supplementary Tables from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
2023Open Access
Supplementary fig 4 from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
2023Open Access
Supplementary Data from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
2023Open Access
Supplementary Data 3 from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
2023Open Access
Supplementary Data 1 from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Bruce Mickey(14), Kimmo J. Hatanpaa(11), Elizabeth A. Maher(11), Toral Patel(10), Changho Choi(9), Vivek Tiwari(9), Zhongxu An(8), Sandeep Ganji(7), Marco C. Pinho(6), Patrick Y. Wen(5), Robert Bachoo(5), Jack Raisanen(5), Amyn A. Habib(5), David A. Reardon(4), Michael Glantz(4), Renato V. LaRocca(4), Karen Fink(4), Glenn J. Lesser(4), Santosh Kesari(4), Vamsidhara Vemireddy(4)